Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

TCR2 THERAPEUTICS INC. (TCRR)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsMar-31-23Mar-05-23Dec-31-22Dec-05-22Sep-30-22Sep-05-22Jun-30-22Mar-31-22
   10-Q8-K10-K8-K10-Q8-K10-Q10-Q
Revenues   [+]0.029.30.025.70.024.80.00.0
            Revenue growth   31.1% 37.3% 22.3%  
Cost of goods sold  0.062.60.061.40.031.10.00.0
Gross profit  0.0-33.30.0-35.70.0-6.30.00.0
            Gross margin   -113.8% -138.7% -25.5%  
Selling, general and administrative   [+]41.58.261.45.831.16.331.829.2
Research and development          
Other operating expenses  -6.3 -32.419.9-1.018.5-0.6-0.8
EBITDA   [+]-34.6-40.9-28.2-60.7-29.2 -30.5-27.7
            EBITDA margin   -139.7% -235.8% -125.5%  
Depreciation and amortization  0.60.60.70.70.9 0.70.7
EBIT   [+]-35.2-41.5-29.0-61.4-30.1-31.1-31.2-28.4
            EBIT margin   -141.8% -238.7% -125.5%  
Non-recurring items   [+]4.0 30.4    0.6
Interest income   1.1 1.0 0.5  
Other income (expense), net  -1.1 -1.0 -0.5 -0.3-0.1
Pre-tax income  -40.4-40.4-60.4-60.4-30.6-30.6-31.5-29.1
Income taxes  0.00.00.10.10.00.00.10.0
            Tax rate   0.0%      
Net income  -40.40.0-60.5-60.5-30.6-30.6-31.6-29.1
            Net margin   0.0% -235.1% -123.4%  
   
Basic EPS   [+]($1.03)$0.00($1.57)($1.56)($0.79)($0.79)($0.82)($0.76)
Diluted EPS   [+]($1.03)$0.00($1.57)($1.56)($0.79)($0.79)($0.82)($0.76)
   
Shares outstanding (basic)   [+]39.239.238.638.838.638.638.638.5
Shares outstanding (diluted)   [+]39.239.238.638.838.638.638.638.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy